Indocyanine green angiography guided management of vogt-koyanagi-harada disease

Journal of Ophthalmic and Vision Research

Volumn 6, Issue 4, 2011, Pages 241-248

  Bouchenaki, Nadia ^a,b   Herbort, Carl P ^a,c  

^a Centre for Ophthalmic Specialized Care (COS)   (Switzerland)

^b Clinique Generale de Beaulieu   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Indocyanine green angiography; Therapy; Vogt koyanagi harada disease

Indexed keywords

EID: 84855577348     PISSN: 20082010     EISSN: 2008322X     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bouchenaki N, Herbort CP. Stromal choroiditis. In: Pleyer U, Mondino B (eds). Essentials in Ophthalmology: Uveitis and Immunological Disorders. 1st ed. Berlin, Heidelberg, New York: Springer; 2004: 234-253.
2. Sugita S, Takase H, Taguchi C, Imai Y, Kamoi K, Kawaguchi T, et al. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci 2006;47:2547-2554.
3. Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, et al. T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis. Invest Ophthalmol Vis Sci 2005;46:2465-2471.
4. Sonoda S, Nakao K, Ohba N. Extensive chorioretinal atrophy in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 1999;43:113-119.
5. Rao NA. Treatment of Vogt-Koyanagi-Harada disease by corticosteroids and immunosuppressive agents. Ocul Immunol Inflamm 2006;14:71-72.
6. Bouchenaki N, Morisod L, Herbort CP. Vogt- Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention. Klin Monbl Augenheilkd 2000;216:290-294.
7. Nussenblatt RB. Vogt-Koyanagi-Harada syndrome. In: Nussenblatt RB, Whitcup SM (eds). Uveitis: Fundamentals and Clinical Practice. 3rd ed. Philadelphia: Mosby; 2004: 324-338.
8. Rao NA, Inomata H, Moorthy RS. Vogt-Koyanagi- Harada syndrome. In: Pepose JS, Holland GN, Wilhelmus KR (eds). Ocular Infection and Immunity. 1st ed. St. Louis: Mosby; 1996: 734-753.
9. Tugal-Tutkun I, Ozyazgan Y, Akova Y, Sullu Y, Akyol N, Soylu M, et al The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey. Int Ophthalmol 2007;27:117-123.
10. Keino H, Goto H, Usui M. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic inflammation. Graefes Arch Clin Exp Ophthalmol 2002;240:878-882.
11. Yang P, Wang H, Zhou H, Huang X, Zhong H, Chen L, et al. Clinical manifestations and diagnosis of Vogt-Koyanagi-Harada syndrome. Zhonghua Yan Ke Za Zhi 2002;38:736-739.
12. Foster DJ, Cano MR, Green RL, Rao NA. Echographic features of the Vogt-Koyanagi-Harada Syndrome. Arch Ophthalmol 1990;108:1421-1426.
13. Bouchenaki N, Cimino L, Auer C, Tao Tran V, Herbort CP. Assessment and classification of choroidal vasculitis in posterior uveitis using indocyanine green angiography. Klin Monbl Augenheilkd 2002;219:243-249.
14. Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt-Koyanagi- Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol 2007;27:173-182.
15. Kawaguchi T, Horie S, Bouchenaki N, OhnoMatsui K, Mochizuki M, Herbort CP. Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease. Int Ophthalmol 2010;30:41-50.
16. Miyanaga M, Kawaguchi T, Miyata K, Horie S, Mochizuki M, Herbort CP. Indocyanine green angiography findings in initial acute pretreatment Vogt-Koyanagi-Harada disease in Japanese patients. Jpn J Ophthalmol 2010;54:377-382.
17. Bascal K, Wen DS, Chee SP. Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2008;145:480-486.
18. Howe L Stanford M, Graham E, Marshall J. Indocyanine green angiography in inflammatory eye diseases. Eye 1998;12:761-767.
19. Harada T, Kanbara Y, Takeuchi T, Niwa T, Majima T. Exploration of Vogt-Koyanagi Harada syndrome by infrared choroidal angiography with indocyanine green. Eur J Ophthalmol 1997;7:163-170.
20. Oshima Y, Harino S, Hara Y, Tano Y. Indocyanine green angiographic findings in Vogt-Koyanagi- Harada disease. Am J Ophthalmol 1996;122:58-66.
21. Okada AA, Mizusawa T, Sakai J, Usui M. Videofunduscopy and videoangiography using the scanning laser ophthalmoscope in Vogt-Koyanagi- Harada syndrome. Br J Ophthalmol 1998;82:1175-1181.
22. Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology 2001;108:54-64.
23. Herbort CP, LeHoang P, Guex-Crosier Y. Schematic interpretation of indocyanine green angiography in posterior uveitis using a standard protocol. Ophthalmology 1998;105:432-440.
24. Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 1991;109:682-687.
25. Mantovani A, Resta A, Herbort CP, Abu El Asrar A, Kawaguchi T, Mochizuki M, et al. Work-up, diagnosis and management of acute Vogt-Koyanagi- Harada disease: a case of acute myopization with granulomatous uveitis. Int Ophthalmol 2007;27:100-115.
26. Maruyama Y, Kimura Y, Kishi S, Shimizu K. Serous detachment of the ciliary body in Harada disease. Am J Ophthalmol 1988;125:666-672.
27. Yamanaka E, Ohguro N, Yamamoto S, Nakagawa Y, Imoto Y, Tano Y. Evaluation of pulse corticosteroid therapy for Vogt-Koyanagi-Harada disease assessed by optical coherence tomography. Am J Ophthalmol 2002;134:454-456.
28. Suzuki S. Quantitative evaluation of "sunset-glow" fundus in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 1999;43:327-333.
29. Chee SP, Jap A, Bacsal K. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore. Am J Ophthalmol 2009;147:154-161.
30. Inomata H, Rao NA. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001;131:607-614.
31. Papadia M, Herbort CP. Idiopathic choroidal neovascularization as the inaugural sign of multiple evanescent white dot syndrome. Middle East Afr J Ophthalmol 2010;17:270-274.
32. Papadia M, Herbort CP. Unilateral papillitis, the tip of the iceberg of bilateral ICGA-detected tuberculous choroiditis. Ocul Immuno Inflamm 2011;19:124-126.
33. Bouchenaki N, Herbort CP. Indocyanine green angiography (ICGA) in the assessment and followup of choroidal inflammation in active chronically evolving Vogt-Koyanagi-Harada disease. In: Dodds EM, Couto CA (eds). Uveitis in the third millennium. 1st ed. Buenos Aires: Elsevier Science B.V.; 2000: 35-38.
34. Herbort CP, Bodaghi B, Lehoang P. Indocyanine green angiography in ocular inflammatory diseases: principles, schematic interpretation, semiology and clinical value. J Fr Ophthalmol 2001;24:423-447.
35. Altan-Yaycioglu R, Akova YA, Akca S, Yilmaz G. Inflammation of the posterior uvea: findings on fundus fluorescein and indocyanine green angiography. Ocul Immunol Inflamm 2006;14:171-179.
36. Chen L, Yang P, Wen F, Zhou H, Huang X. Fundus fluorescein and indocyanine green angiographic study of Behçet's disease and Vogt-Koyanagi- Harada syndrome. Zhonghua Yan Ke Za Zhi 2002;38:210-212.
37. Kohno T, Miki T, Shiraki K, Kano K, Matsushita M, Hayashi K, et al. Subtraction ICG angiography in Harada's disease. Br J Ophthalmol 1999;83:822-833.
38. Herbort CP. Indocyanine Green Angiography. In: Gupta A, Gupta V, Herbort CP, Khairallah M (eds). Uveitis, Text and Imaging. 1st ed. New Delhi: Jaypee; 2009: 88-143.
39. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-652.